Literature DB >> 33445394

Dual Channel Activatable Cyanine Dye for Mitochondrial Imaging and Mitochondria-Targeted Cancer Theranostics.

Guang-Yu Pan1, Hao-Ran Jia1, Ya-Xuan Zhu1, Ruo-Han Wang1, Fu-Gen Wu1, Zhan Chen2.   

Abstract

Because mitochondria are the key regulators for many cellular behaviors and are susceptible to hyperthermia and reactive oxygen species, mitochondria-specific reagents for simultaneous targeting, imaging, and treatment are highly desirable in cancer theranostics. Herein, we developed a mitochondria-targeted cyanine dye IR825-Cl, which possesses two separated excitation wavelength channels for both red fluorescence imaging and near-infrared (NIR) photothermal therapy (PTT). For imaging, IR825-Cl rapidly entered cells and selectively targeted mitochondria. Although IR825-Cl was completely quenched in water, interestingly, this dye had a turn-on response of red fluorescence (610 nm) in mitochondria under 552 nm excitation due to its polarity-responsive fluorescence emission. More interestingly, IR825-Cl realized the selective mitochondrial staining of cancer cells over normal cells and thus served as an ideal fluorescent probe for identifying cancer cells in normal tissues, which is extremely beneficial for cancer theranostics. For PTT, we demonstrated that under 808 nm NIR laser irradiation, this dye efficiently converted optical energy into heat, realizing mitochondria-targeted photothermal cancer therapy. Collectively, this molecule realized both high fluorescence emission (quantum yield > 43%) and effective light-to-heat conversion (17.4%), enabling its applications for wash-free fluorescence imaging for mitochondria and highly efficient fluorescence imaging-guided PTT.

Entities:  

Keywords:  cell differentiation; mitochondrial imaging/tracking; near-infrared heptamethine cyanine dye; photothermal therapy; turn-on response of visible light fluorescence

Year:  2017        PMID: 33445394     DOI: 10.1021/acsbiomaterials.7b00480

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  9 in total

Review 1.  Recent advances in bioprobes and biolabels based on cyanine dyes.

Authors:  Xiaoying Ma; Lei Shi; Buyue Zhang; Lu Liu; Yao Fu; Xiufeng Zhang
Journal:  Anal Bioanal Chem       Date:  2022-03-31       Impact factor: 4.142

2.  A Novel Fluorescent Dye Extracted from Buddleja officinalis for Labeling Mitochondria after Fixation.

Authors:  Ying Yang; Ok-Su Kim; Byunggook Kim; Guo Liu; Jianan Song; Danyang Liu; Guowu Ma; Young Kim; Okjoon Kim
Journal:  Scanning       Date:  2022-06-03       Impact factor: 1.750

3.  Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma.

Authors:  Wei-Nan Zeng; Qiu-Ping Yu; Duan Wang; Jun-Li Liu; Qing-Jun Yang; Zong-Ke Zhou; Yi-Ping Zeng
Journal:  J Nanobiotechnology       Date:  2021-03-19       Impact factor: 10.435

4.  Photostable near-infrared-absorbing diradical-platinum(ii) complex solubilized by albumin toward a cancer photothermal therapy agent.

Authors:  Ryota Sawamura; Masataka Sato; Atsuko Masuya-Suzuki; Nobuhiko Iki
Journal:  RSC Adv       Date:  2020-02-11       Impact factor: 3.361

5.  Fluorescent Imaging Probe Targeting Mitochondria Based on Supramolecular Host-Guest Assembly and Disassembly.

Authors:  Ning Chu; Lili Cong; Jing Yue; Weiqing Xu; Shuping Xu
Journal:  ACS Omega       Date:  2022-09-15

6.  All-in-one mitochondria-targeted NIR-II fluorophores for cancer therapy and imaging.

Authors:  Yujia Zheng; Qianqian Li; Jing Wu; Ziyi Luo; Wenyi Zhou; Anguo Li; Yanling Chen; Tuerxunayi Rouzi; Tian Tian; Hui Zhou; Xiaodong Zeng; Yang Li; Xiaoding Cheng; Yongchang Wei; Zixin Deng; Fuling Zhou; Xuechuan Hong
Journal:  Chem Sci       Date:  2020-11-27       Impact factor: 9.825

Review 7.  Low-Temperature Photothermal Therapy: Strategies and Applications.

Authors:  Xiulin Yi; Qiu-Yi Duan; Fu-Gen Wu
Journal:  Research (Wash D C)       Date:  2021-05-07

Review 8.  Recent Advances in Cyanine-Based Phototherapy Agents.

Authors:  Kubra Bilici; Sultan Cetin; Eda Aydındogan; Havva Yagci Acar; Safacan Kolemen
Journal:  Front Chem       Date:  2021-06-24       Impact factor: 5.221

9.  N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity.

Authors:  Mahboubeh Varmazyad; Mira M Modi; Amanda L Kalen; Ehab H Sarsour; Brett Wagner; Juan Du; Michael K Schultz; Garry R Buettner; F Christopher Pigge; Prabhat C Goswami
Journal:  Free Radic Biol Med       Date:  2021-02-06       Impact factor: 8.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.